Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Canaccord Fireside Chat & pelareorep's approval in mBC

<< Previous

Bullboard Posts

Next >>

Comment by Buckhenryon Aug 13, 2023 10:22pm

89 Views

Post# 35586379

RE:RE:RE:RE:RE:RE:Canaccord Fireside Chat & pelareorep's approval in mBC

If it was not for Google searches and copy and paste.... the dreamers would have nothing to say. Has the outcome thus far been impacted by anything that the dreamers have posted over and over here? I guess each one will have to answer that on their own. In the mean time we wait. We all seek a similar outcome... the difference is dreaming versus a realistic approach.

<< Previous

Bullboard Posts

Next >>

Yukon agency detects cyanide near Victoria Gold's Eagle mine